171 related articles for article (PubMed ID: 32033899)
1. The effect of targeted insurer-mandated prescription monitoring on opioid prescribing patterns.
Fleming JN; Zhang J; Taber DJ; McCauley JL; Schumann S; Mauldin PD; Ball S
J Am Pharm Assoc (2003); 2020; 60(4):559-564. PubMed ID: 32033899
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Postoperative Opioid Prescriptions Before and After Implementation of a Mandatory Prescription Drug Monitoring Program.
Shenoy R; Wagner Z; Kirkegaard A; Romanelli RJ; Mudiganti S; Mariano L; Martinez M; Zanocco K; Watkins KE
JAMA Health Forum; 2021 Oct; 2(10):e212924. PubMed ID: 35977161
[TBL] [Abstract][Full Text] [Related]
3. Assessing the impact of a restrictive opioid prescribing law in West Virginia.
Sedney CL; Khodaverdi M; Pollini R; Dekeseredy P; Wood N; Haggerty T
Subst Abuse Treat Prev Policy; 2021 Feb; 16(1):14. PubMed ID: 33526045
[TBL] [Abstract][Full Text] [Related]
4. Impact of Iowa's Prescription Monitoring Program on Opioid Pain Reliever Prescribing Patterns: An Interrupted Time Series Study 2003-2014.
Ranapurwala SI; Carnahan RM; Brown G; Hinman J; Casteel C
Pain Med; 2019 Feb; 20(2):290-300. PubMed ID: 29509935
[TBL] [Abstract][Full Text] [Related]
5. Effect of Payor-Mandated Review of Prescription Drug Monitoring Program on Opioid Prescriber Rates.
Schumann SO; Zhang J; McCauley JL; Heidari K; Ball SJ
South Med J; 2020 Sep; 113(9):415-417. PubMed ID: 32885255
[TBL] [Abstract][Full Text] [Related]
6. Impact of prescription drug monitoring program mandate on postoperative opioid prescriptions in children.
Theodorou CM; Jackson JE; Rajasekar G; Nuño M; Yamashiro KJ; Farmer DL; Hirose S; Brown EG
Pediatr Surg Int; 2021 May; 37(5):659-665. PubMed ID: 33433663
[TBL] [Abstract][Full Text] [Related]
7. Association Between Statewide Opioid Prescribing Interventions and Opioid Prescribing Patterns in North Carolina, 2006-2018.
Maierhofer CN; Ranapurwala SI; DiPrete BL; Fulcher N; Ringwalt CL; Chelminski PR; Ives TJ; Dasgupta N; Go VF; Pence BW
Pain Med; 2021 Dec; 22(12):2931-2940. PubMed ID: 34175958
[TBL] [Abstract][Full Text] [Related]
8. Impact of a prescription drug monitoring program use mandate on potentially problematic patterns of opioid analgesic prescriptions in New York City.
Bachhuber MA; Tuazon E; Nolan ML; Kunins HV; Paone D
Pharmacoepidemiol Drug Saf; 2019 May; 28(5):734-739. PubMed ID: 30920062
[TBL] [Abstract][Full Text] [Related]
9. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
[TBL] [Abstract][Full Text] [Related]
10. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines.
Manders L; Abd-Elsayed A
Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396
[TBL] [Abstract][Full Text] [Related]
11. Changes in opioid prescribing after implementation of mandatory registration and proactive reports within California's prescription drug monitoring program.
Castillo-Carniglia A; González-Santa Cruz A; Cerdá M; Delcher C; Shev AB; Wintemute GJ; Henry SG
Drug Alcohol Depend; 2021 Jan; 218():108405. PubMed ID: 33234299
[TBL] [Abstract][Full Text] [Related]
12. The Supply of Prescription Opioids: Contributions of Episodic-Care Prescribers and High-Quantity Prescribers.
Schneberk T; Raffetto B; Kim D; Schriger DL
Ann Emerg Med; 2018 Jun; 71(6):668-673.e3. PubMed ID: 29275945
[TBL] [Abstract][Full Text] [Related]
13. Effect of a legislative mandate on opioid prescribing for back pain in the emergency department.
Khobrani M; Perona S; Patanwala AE
Am J Emerg Med; 2019 Nov; 37(11):2035-2038. PubMed ID: 30824275
[TBL] [Abstract][Full Text] [Related]
14. The effect of an opioid prescription days' supply limit on patients receiving long-term opioid treatment.
Yenerall J; McPheeters M
Int J Drug Policy; 2020 Mar; 77():102662. PubMed ID: 31968287
[TBL] [Abstract][Full Text] [Related]
15. Changes in Surgical Opioid Prescribing and Patient-Reported Outcomes After Implementation of an Insurer Opioid Prescribing Limit.
Chua KP; Nguyen TD; Brummett CM; Bohnert AS; Gunaseelan V; Englesbe MJ; Waljee JF
JAMA Health Forum; 2023 Oct; 4(10):e233541. PubMed ID: 37831460
[TBL] [Abstract][Full Text] [Related]
16. Differential patterns of opioid misuse between younger and older adults - a retrospective observational study using data from South Carolina's prescription drug monitoring program.
Zhang S; Silverman A; Suen SC; Andrews C; Chen BK
Am J Drug Alcohol Abuse; 2022 Sep; 48(5):618-628. PubMed ID: 36194086
[No Abstract] [Full Text] [Related]
17. Impact of Statewide Statute Limiting Days' Supply to Opioid-Naive Patients.
Sullivan KJ; Gabella B; Ziegler K; Tolle H; Giano Z; Hoppe J
Am J Prev Med; 2024 Jan; 66(1):112-118. PubMed ID: 37604303
[TBL] [Abstract][Full Text] [Related]
18. Opioid days' supply limits: an interrupted time-series analysis of opioid prescribing before and following a Massachusetts law.
Hackman HH; Young LD; Galanto D; Johnson D; Xuan Z
Am J Drug Alcohol Abuse; 2021 May; 47(3):350-359. PubMed ID: 33428460
[No Abstract] [Full Text] [Related]
19. Trends and Patterns of Geographic Variation in Opioid Prescribing Practices by State, United States, 2006-2017.
Schieber LZ; Guy GP; Seth P; Young R; Mattson CL; Mikosz CA; Schieber RA
JAMA Netw Open; 2019 Mar; 2(3):e190665. PubMed ID: 30874783
[TBL] [Abstract][Full Text] [Related]
20. High-Risk Opioid Prescribing Trends: Prescription Drug Monitoring Program Data From 2010 to 2018.
Ball SJ; Simpson K; Zhang J; Marsden J; Heidari K; Moran WP; Mauldin PD; McCauley JL
J Public Health Manag Pract; 2021 Jul-Aug 01; 27(4):379-384. PubMed ID: 32956292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
